share_log

Akero Therapeutics | 8-K: Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

SEC ·  Mar 17, 2023 19:33
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more